Info

Repligen Corporation (Repligen) develops therapeutics for the treatment of diseases of the central nervous system. The Company sells a line of Protein A, which is used in the production of monoclonal antibodies, and SecreFlo, a synthetic form of the hormone secretin, which is used as an aid in the diagnosis of certain diseases of the pancreas. The Company sells its Protein A products primarily through value-added resellers, including GE Healthcare (GEHC) and Applied Biosystems, Inc., as well as through distributors in certain foreign markets. It markets SecreFlo directly to gastroenterologists in the United States. The Company also owns intellectual property on monoclonal antibody and antibody fusion products.(Source: 10-K)